Internet Pioneer In...
Health Care: Drugs
Durect Corporation (DRRX: NASDAQ)
$0.82 -0.01 | -1.10%
06/04/12 - 09:38 AM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 20,000 | 0 | -20,000 | -20,000 | -20,000 | 0 | 0 |
| Shares Bought | 20,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 20,000 | 20,000 | 20,000 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 45.84M | 49.90M | 51.55M | 51.60M | 51.85M | 51.85M | 52.59M |
| Shares Bought | 11.87M | 12.94M | 8.80M | 8.78M | 4.38M | 4.38M | 4.38M |
| Shares Sold | 13.58M | 10.99M | 9.13M | 9.22M | 4.80M | 4.80M | 4.74M |
Portfolios with DRRX
- Portfolio NameUser Type
- ProRobert Bruce
- Userdonellisor
- UserTrading
- Userbaustin002 Portfolio 1
- UserBarron's Research Reports 1...
- Userhititbig
- Userbv2
- UserFBSPANKEY Portfolio 1
- Usersandw1ch Portfolio 1
- Usermiguele4 Portfolio 1
Latest DRRX Headlines from TheStreet
- Business Highlights 06.24.11 | 06:06 pm
- Durect Stock Gaps Down On Today's Open (DRRX) 06.24.11 | 09:06 am
- Pfizer, Pain Therapeutics Drug Rejected by FDA 06.24.11 | 08:06 am
- 10 Stocks to Watch: Alcoa, BP 04.12.11 | 06:04 am
- Biotech Calendar: 2011 FDA Drug Approvals 02.22.11 | 07:02 am
- DURECT Corporation To Participate In Upcoming Healthcare Conferences 09.07.10 | 06:09 pm
- DURECT Corporation Q1 2010 Earnings Call Transcript 05.11.10 | 01:05 am
- Durect Says Pain Patch Met Goals In Clinical Study 03.16.09 | 02:03 pm
- Thursday's Winners & Losers: Durect 05.08.08 | 04:05 pm
- Health Winners & Losers: Barr 05.08.08 | 04:05 pm
Press Releases for DRRX
- DURECT Receives Back U.S. And Canadian Product Rights To POSIDUR⢠- PR Newswire 03.29.12 | 04:03 pm
- DURECT Corporation Invites You To Join Its Fourth Quarter 2011 Earnings Conference Call - PR Newswire 02.24.12 | 09:02 am
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 02.23.12 | 11:02 am
- DURECT To Present At The BIO CEO & Investor Conference - PR Newswire 02.07.12 | 12:02 pm
- DURECT Receives Back European Product Rights To POSIDUR⢠- PR Newswire 01.30.12 | 04:01 pm
- DURECT Announces Top-line Data From BESST (POSIDUR® U.S. Pivotal Phase III Trial) - PR Newswire 01.05.12 | 04:01 pm
- DURECT Corporation To Participate In Upcoming Healthcare Conferences - PR Newswire 11.07.11 | 08:11 am
- DURECT Corporation Invites You To Join Its Third Quarter 2011 Earnings Conference Call - PR Newswire 10.26.11 | 05:10 pm
- DURECT Completes Enrollment In Pivotal U.S. Phase III Trial For POSIDUR® (BESST) - PR Newswire 09.06.11 | 07:09 am
- DURECT Corporation To Participate In Upcoming Healthcare Conferences - PR Newswire 08.31.11 | 04:08 pm
Partner Headlines for DRRX
- Pfizer Terminates Development and License Agreement Between Alpharma Ireland and DURECT - Benzinga 03.01.12 | 04:03 pm
- DURECT Announces Top-line Data from BESST; Did Not Reach Statistical Significance - Benzinga 01.05.12 | 04:01 pm
- 12 Healthcare Companies Looking at June Catalysts - Seeking Alpha 05.30.11 | 04:05 am
- Jefferies Reiterates Buy Rating on DURECT Corp. (DRRX) - Benzinga 08.05.10 | 09:08 am
- FDA Clears Hospira's Generic Drug - Analyst Blog - Zacks 06.25.10 | 01:06 pm
- UPDATE 1-Durect's pain drug shows mixed results in EU trial - Reuters 06.16.10 | 05:06 pm
- King Advances Pain Candidate - Analyst Blog - Zacks 04.08.10 | 06:04 pm
